Phase II/III randomized immunogenicity and safety study of a Brazilian meningococcal serogroup B vaccine in children. - Martins RM; Maia MLS; Camacho LAB; Noronha TG; von Doellinger VR; Santos AP; Figueira ES; Leal ML; Jessouroun E (Vaccine, 2025)